| scholarly article | Q13442814 |
| P50 | author | Linda S. Hynan | Q37370246 |
| P2093 | author name string | Liping Li | |
| Qun Xiang | |||
| Roger N Rosenberg | |||
| Bao-Xi Qu | |||
| Stephen Albert Johnston | |||
| P2860 | cites work | Alzheimer's disease: genes, proteins, and therapy | Q28131806 |
| Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse | Q29619237 | ||
| In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis | Q30445028 | ||
| Immune function of astrocytes | Q34398643 | ||
| Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. | Q34417339 | ||
| Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. | Q34568588 | ||
| Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety | Q34687112 | ||
| Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease | Q34693094 | ||
| Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology | Q34763076 | ||
| Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigene | Q34881830 | ||
| Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice. | Q34928142 | ||
| Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning | Q34932593 | ||
| Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease | Q35169132 | ||
| Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease | Q35998995 | ||
| Role of the APP promoter in Alzheimer's disease: cell type-specific expression of the beta-amyloid precursor protein | Q36014086 | ||
| Mechanisms of neuronal degeneration in Alzheimer's disease | Q40986730 | ||
| Production of the Alzheimer amyloid beta protein by normal proteolytic processing | Q41599298 | ||
| Amyloid beta-peptide is produced by cultured cells during normal metabolism | Q41602809 | ||
| Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide | Q45295828 | ||
| Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease | Q47229361 | ||
| A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease | Q47583762 | ||
| The role of antibody concentration and avidity in antiviral protection. | Q47620972 | ||
| ELISPOT assay for detection of peptide specific interferon-gamma secreting cells in rhesus macaques | Q47876181 | ||
| Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). | Q48092766 | ||
| GFAP and astrogliosis | Q48098562 | ||
| The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture | Q48579960 | ||
| Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. | Q48893777 | ||
| Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma | Q49069882 | ||
| Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells. | Q51106696 | ||
| APP gene promoter constructs are preferentially expressed in the CNS and testis of transgenic mice. | Q52191874 | ||
| Endogenous IL-4 and IFN-γ are essential for expression of Th2, but not Th1 cytokine message during the early differentiation of human CD4+ T helper cells | Q57275803 | ||
| Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome | Q72107326 | ||
| Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances | Q72390162 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 204-213 | |
| P577 | publication date | 2007-06-15 | |
| P1433 | published in | Journal of the Neurological Sciences | Q6296168 |
| P1476 | title | Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice | |
| P478 | volume | 260 |
| Q39373266 | A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients |
| Q33855619 | A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease. |
| Q38112430 | Active DNA Aβ42 vaccination as immunotherapy for Alzheimer disease. |
| Q59336577 | Active full-length DNA Aβ immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology |
| Q38183140 | Active immunotherapy options for Alzheimer's disease |
| Q36965988 | Advances in the development of vaccines for Alzheimer's disease |
| Q35792042 | Amyloid-β immunization enhances neurogenesis and cognitive ability in neonatal mice. |
| Q34080692 | Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease |
| Q38219981 | Anti-amyloid beta to tau - based immunization: Developments in immunotherapy for Alzheimer disease |
| Q53427707 | Application of immunosignatures to the assessment of Alzheimer's disease. |
| Q47596419 | Astrocytes with previous chronic exposure to amyloid β-peptide fragment 1-40 suppress excitatory synaptic transmission |
| Q33390631 | Binding and uptake of A beta1-42 by primary human astrocytes in vitro |
| Q35000579 | Co-stimulation with TNF receptor superfamily 4/25 antibodies enhances in-vivo expansion of CD4+CD25+Foxp3+ T cells (Tregs) in a mouse study for active DNA Aβ42 immunotherapy |
| Q33829380 | DNA Aβ42 vaccination as possible alternative immunotherapy for Alzheimer disease. |
| Q33957114 | DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model. |
| Q41783861 | DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation |
| Q28714253 | Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network |
| Q37303082 | Epitope-based DNA vaccine for Alzheimer's disease: translational study in macaques |
| Q37693367 | Evaluation of a DNA Aβ42 Vaccine in Aged NZW Rabbits: Antibody Kinetics and Immune Profile after Intradermal Immunization with Full-Length DNA Aβ42 Trimer |
| Q33604583 | Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer |
| Q38822996 | Genomics of Alzheimer Disease: A Review. |
| Q24599108 | Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease |
| Q38187861 | Immunogenicity of DNA- and recombinant protein-based Alzheimer disease epitope vaccines |
| Q37530061 | Immunotherapeutic efficiency of a tetravalent Aβ1-15 vaccine in APP/PS1 transgenic mice as mouse model for Alzheimer's disease |
| Q48603497 | In vivo electroporation of a new gene vaccine encoding ten repeats of Aβ3-10 prevents brain Aβ deposition and delays cognitive impairment in young Tg-APPswe/PSEN1dE9 mice |
| Q89351841 | Intradermal active full-length DNA Aβ42 immunization via electroporation leads to high anti-Aβ antibody levels in wild-type mice |
| Q37357640 | Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease |
| Q51481172 | Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease. |
| Q39432793 | The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model |
| Q33560798 | The MultiTEP platform-based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates |
| Q57291631 | Trans-cinnamaldehyde Modulates Hippocampal Nrf2 Factor and Inhibits Amyloid Beta Aggregation in LPS-Induced Neuroinflammation Mouse Model |
| Q36552898 | Yeast expressed foldable quadrivalent Aβ15 elicited strong immune response against Aβ without Aβ-specific T cell response in wild C57BL/6 mice |
Search more.